Recall that KERX is perfectly priced to dupe small investors and rob them of their hard earned cash.
Just so you guys know, at best KERX goes to 3 dollars...and you'll need to wait till 2013.
Don't ask me, ask any of your "community leaders." Oh by the way, you're what we call a "muppet" if a feel good message has any effect on your investment here.
Let's look at the facts presented by all:
3 dollar share price at best, 2013
You know...I was thinking If I put all my savings into this stock it might double by 2013? Oh...just kidding, that's easily the worst idea I can fathom.
Given the current stock price of around 1.7, which is due to sink to 1.4-1.5, even at best, you can gain $1.50 off this stock's success if Zerenex succeeds flawlessly, but to be very very honest, if you don't expect a delay on Zerenex you're kind of a muppet.
Invest savings into fail biotech (June 2012) Hoping for 1.5 dollars per share profit (July 2012 gone) 30 days of trading time (August 2012 gone) 60 days (September 2012 gone) 90 days (November 2012 gone) 120 days (December 2012 gone)150 days (January 2013 gone) 180 days (February 2013 gone) 210 days (March 2013 gone) 240 days (April 2013 -- PLEASE LET THERE BE NEWS SOON) (Late April 2013 -- Expected delay occurs for safety concerns not validly addressed by study) 270 (May 2013) 300 days (June 2013) 330 days (July 2013) 360 days (An entire year of trading time has passed waiting for 1.5 dollars per share) (August 2013) 390 days (September 2013) 420 days (November 2013) 450 days (December 2013) 470 days (2014???) Generics > Zerenex? 500 days trading time wasted on plans to profit from a small PPS increase over 2 years?
Not a good investment. Zerenex is ready? + 1.50 per share over 2 years?
(THEIR SUCCESS ISN'T EVEN IN THEIR HANDS, ITS UNDER REGULATORY CONTROL)
And to be honest, anyone should have learned from Perifosine's failure. That drug failed because the study was flawed. They took a sample of some very isolated Phase II results and ran with their hopes and dreams that the drug actually does something, in retrospect, we look at the Phase II Perifosine results and its very clear they gambled on that one.
What about Zerenex? To me its a gamble...and I wouldn't be surprised if it was a gamble for KERX too.